Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeGregory G. Schwartz, R. Scott Wright, Anders Olsson et al.|New England Journal of Medicine|2012Cited by 2k
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Daniel Gaudet, Lesley Burgess et al.|The Lancet|2014Cited by 750
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-CarboxamidesPer Björk, Tomas Leanderson, Anders Björk et al.|PLoS Biology|2009Cited by 358
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated DyslipidemiaPaul W. Ladenson, Bo Angelin, Jens D. Kristensen et al.|New England Journal of Medicine|2010Cited by 334
S100A9 Interaction with TLR4 Promotes Tumor GrowthEva Källberg, Tomas Leanderson, Thomas Vogl et al.|PLoS ONE|2012Cited by 138